Cart
sales@molnova.com
Moguisteine
CAS No. 119637-67-1
Moguisteine( BBR-2173 | BBR2173 | BBR 2173 )
Catalog No. M10692 CAS No. 119637-67-1
Moguisteine is a novel peripheral non-narcotic antitussive drug.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 50MG | 27 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMoguisteine
-
NoteResearch use only, not for human use.
-
Brief DescriptionMoguisteine is a novel peripheral non-narcotic antitussive drug.
-
DescriptionMoguisteine is a novel peripheral non-narcotic antitussive drug.
-
In Vitro——
-
In Vivo——
-
SynonymsBBR-2173 | BBR2173 | BBR 2173
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number119637-67-1
-
Formula Weight339.41
-
Molecular FormulaC16H21NO5S
-
Purity>98% (HPLC)
-
SolubilityEthanol: 68 mg/mL (200.34 mM); DMSO: 68 mg/mL (200.34 mM)
-
SMILESO=C(OCC)CC(N1C(COC2=CC=CC=C2OC)SCC1)=O
-
Chemical Nameethyl 3-(2-((2-methoxyphenoxy)methyl)thiazolidin-3-yl)-3-oxopropanoate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gallico L, et al. Br J Pharmacol, 1994, 112(3), 795-800.
molnova catalog
related products
-
Schisantherin B
Schisantherin B shows good effect in lowering the serum glutamic-pyruvic transaminase level of the patients suffering from chronic virus hepatitis.
-
Compound 35
Compounds 35 are superior inhibitors of Ebola (Mayinga) and Marburg (Angola) infectious viruses.Compounds 35 are superior inhibitors of Ebola (Mayinga) and Marburg (Angola) infectious viruses. Compounds 35 have shown good metabolic stability in plasma and liver microsomes (rat and human), and 32 did not inhibit CYP3A4 nor CYP2C9.
-
6-O-p-Hydroxybenzoyl...
6'''-O-p-Hydroxybenzoylsaponarin
